Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jan 15, 2024; 16(1): 118-132
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.118
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.118
Table 1 Differential expression of pSmad3(S423/425), TGF-β1 and VEGFR-1 protein in gastric cancer tissue
| IHC grading | pSmad3(S423/425) | TGF-β1 | VEGFR-1 | ||||||
| Tumor | Ad-tissue | P value | Tumor | Ad-tissue | P value | Tumor | Ad-tissue | P value | |
| - | 5 | 4 | < 0.05 | 3 | 3 | < 0.001 | 13 | 12 | < 0.001 |
| + | 43 | 38 | 31 | 58 | 27 | 65 | |||
| ++ | 41 | 40 | 56 | 21 | 50 | 3 | |||
| +++ | 9 | 0 | 8 | 0 | 8 | 2 | |||
| n | 98 | 82 | 98 | 82 | 98 | 82 | |||
- Citation: Lv SL, Guo P, Zou JR, Chen RS, Luo LY, Huang DQ. Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study. World J Gastrointest Oncol 2024; 16(1): 118-132
- URL: https://www.wjgnet.com/1948-5204/full/v16/i1/118.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i1.118